Page 15 - பல்கலைக்கழகம் மருத்துவமனை ஹைடெல்பெர்க் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Immunocore Announces Upcoming Presentations at the American Association for Cancer Research . Immunocore Holdings PlcMarch 11, 2021 GMT OXFORDSHIRE, England and CONSHOHOCKEN, Penn. and ROCKVILLE, Md., March 10, 2021 (GLOBE NEWSWIRE) Immunocore (Nasdaq: IMCR), a late-stage biotechnology company pioneering the development of a novel class of T cell receptor (TCR) bispecific immunotherapies designed to treat a broad range of diseases, including cancer, infection and autoimmune disease, today announced that four abstracts highlighting the Company’s lead program, tebentafusp, were accepted at the American Association for Cancer Research (AACR) 2021 Annual Meeting, which will be held virtually from April 10-15, 2021. Two abstracts will be presented as oral presentations including, in the plenary session, Phase 3 data comparing tebentafusp (IMCgp100) with investigator’s choice in first li

Baden wubergUnited statesMarcuso butlerImmunocore debra nielsenJessicac hasselClayton robertsonHead of communicationsUniversity hospital heidelbergImmunocore consilium strategic communicationsPrincess margaret cancer centreExchange commissionAmerican association for cancer researchOriented innovative clinical researchAmerican associationCancer researchSaturday april